"Scleroderma, Diffuse" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.
Descriptor ID |
D045743
|
MeSH Number(s) |
C17.300.799.602 C17.800.784.602
|
Concept/Terms |
Scleroderma, Diffuse- Scleroderma, Diffuse
- Scleroderma, Progressive
- Progressive Scleroderma
- Diffuse Cutaneous Systemic Sclerosis
- Sudden Onset Scleroderma
- Scleroderma, Sudden Onset
- Sclerodermas, Sudden Onset
- Sudden Onset Sclerodermas
- Diffuse Systemic Sclerosis
- Diffuse Systemic Scleroses
- Scleroses, Diffuse Systemic
- Sclerosis, Diffuse Systemic
- Systemic Scleroses, Diffuse
- Systemic Sclerosis, Diffuse
- Diffuse Scleroderma
- Sclerosis, Progressive Systemic
- Progressive Systemic Sclerosis
- Systemic Sclerosis, Progressive
|
Below are MeSH descriptors whose meaning is more general than "Scleroderma, Diffuse".
Below are MeSH descriptors whose meaning is more specific than "Scleroderma, Diffuse".
This graph shows the total number of publications written about "Scleroderma, Diffuse" by people in this website by year, and whether "Scleroderma, Diffuse" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 3 | 0 | 3 |
2020 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Scleroderma, Diffuse" by people in Profiles.
-
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort. Arthritis Res Ther. 2021 06 14; 23(1):170.
-
Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2020 11; 72(11):1892-1896.
-
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. Ann Rheum Dis. 2020 05; 79(5):618-625.
-
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Arthritis Rheumatol. 2020 01; 72(1):125-136.
-
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis. 2020 03; 79(3):379-386.
-
Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival. Arthritis Res Ther. 2019 04 02; 21(1):85.
-
MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice. Blood. 2018 04 26; 131(17):1974-1986.
-
Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis Cohort. J Rheumatol. 2017 06; 44(6):791-794.
-
Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case report. J Med Case Rep. 2015 Jun 10; 9:136.
-
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. Clin Exp Rheumatol. 2014 Nov-Dec; 32(6 Suppl 86):S-109-14.